Improving cancer outcomes requires prioritizing metabolic therapy, nutrition, and exercise alongside or beyond conventional treatments.
4 people · 4 episodes
Lifestyle changes such as nutrition and exercise should be integrated alongside conventional cancer treatments to improve outcomes and mitigate toxicities.
“It doesn't mean that eating healthy and exercise can replace these treatments. It means we march it right alongside treatments to mitigate the toxicities, to improve your vitality during treatment, and then to enhance the treatment outcome for cure after.”
The Rich Roll Podcast · Feb 2026 · 2 episodes · 2.0M views on this topicCurrent standard cancer treatments are often ineffective and toxic, and outcomes could be improved by incorporating metabolic therapy.
“We have drugs that are extremely expensive based on a somatic mutation theory of cancer that are basically not dropping the death rate.”
The Diary of a CEO · Oct 2024 · 1 episode · 10.2M views on this topicExercise is a vital component of cancer treatment that helps patients tolerate therapies better, preserve muscle mass, and improve their prognosis.
“Well, science doesn't support this absolute rest. We already know that people who exercise, especially with a disease like cancer, will feel better, experience less fatigue, and protect their muscle mass.”
Realfooding Podcast · Apr 2026 · 1 episode · 6K views on this topicThe current oncology landscape is failing to produce transformative results and is often driven by problematic financial incentives.
3 people · 3 episodes
The mortality rate for cancer has not improved significantly over the last several decades despite substantial financial investment.
“if you want to measure the success of treatment in cancer then the thing you need to look at peter is what is the age adjusted mortality of cancer today in 2020 you know what it is it is the same as it was in 1930.”
The Peter Attia Drive · Jul 2020 · 1 episode · 6K views on this topicThe oncology industry is heavily influenced by financial incentives that compromise the medical care provided to patients.
“that was my Tipping Point when I realized that the incestuous relationship between Pharma and um the oncology Community the healers had been so corrupted by their money that everything had fallen off the cliff”
Soft White Underbelly · Aug 2024 · 1 episode · 1.3M views on this topicThe current cancer research landscape produces many marginal drugs that provide limited survival benefits, failing to meet the standards of truly transformative outcomes.
“if you look at 71 consecutively approved drugs for the solid cancers as fojo and colleagues did in a famous paper a few years ago the average improvement was 2.1 months”
The Peter Attia Drive · Oct 2020 · 1 episode · 5K views on this topicExtracted by a model; may misattribute who said what.
Showing 10 of 30
Complete months · first on record Jul 2020